MedPath

Solengepras

Generic Name
Solengepras

Relative Bioavailability and Food Effect Study of CVN424

Phase 1
Completed
Conditions
Parkinson's Disease
Interventions
First Posted Date
2022-12-02
Last Posted Date
2024-08-15
Lead Sponsor
Cerevance Beta, Inc.
Target Recruit Count
32
Registration Number
NCT05635461
Locations
🇺🇸

Celerion, Tempe, Arizona, United States

Study of CVN424 in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2018-09-04
Last Posted Date
2019-07-23
Lead Sponsor
Cerevance Beta, Inc.
Target Recruit Count
64
Registration Number
NCT03657030
Locations
🇺🇸

PPD Development, LP, Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath